stars 1 stars 2 stars 3

Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The Sniper balloon occlusion microcatheter sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues.

Embolx, Inc. Questions

The Embolx, Inc. annual revenue was $1 million in 2026.

Michael Allen is the President and CEO of Embolx, Inc..

11 people are employed at Embolx, Inc..

Embolx, Inc. is based in Sunnyvale, California.

The NAICS codes for Embolx, Inc. are [339, 33].

The SIC codes for Embolx, Inc. are [38, 384].

Top Embolx, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users